Quick Answer
COGNITION THERAPEUTICS INC reported Stockholders Equity of $34.27 million for fiscal year 2025.
COGNITION THERAPEUTICS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $34.27M | +82.8% |
| 2024 | $18.75M | -23.4% |
| 2023 | $24.47M | -39.2% |
| 2022 | $40.25M | -21.5% |
| 2021 | $51.27M | +175.2% |
| 2020 | -$68.18M | -16.7% |
| 2019 | -$58.42M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $36.53M | +152.2% | +419.7% |
| June 30, 2025 | $7.03M | -69.5% | -42.7% |
| March 31, 2025 | $12.27M | -57.5% | -34.6% |
| December 31, 2024 | $18.75M | -23.4% | +29.5% |
| September 30, 2024 | $14.48M | -49.9% | -37.1% |
| June 30, 2024 | $23.01M | -33.1% | -20.3% |
| March 31, 2024 | $28.86M | -19.3% | +17.9% |
| December 31, 2023 | $24.47M | -39.2% | -15.4% |
- COGNITION THERAPEUTICS INC showed an increase of +82.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, COGNITION THERAPEUTICS INC’s stockholders equity has grown by 158.7% (from -$58.42 million to $34.27 million).
- The most recent figure is from COGNITION THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: